Literature DB >> 21278225

Thrombotic microangiopathy related to anti-VEGF agents: intensive versus conservative treatment?

H Izzedine, D Sène, J Hadoux, C Gharbi, E Bourry, C Massard, J C Soria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21278225     DOI： 10.1093/annonc/mdq743

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Reappraisal of treatment-induced renal dysfunction in patients receiving antiangiogenic agents in phase I trials.

Authors:  Antonin Levy; Laurence Albiges-Sauvin; Christophe Massard; Hassan Izzedine; Stéphane Ederhy; Stéphane Edhery; Ratio Bahleda; Carlos Gomez-Roca; Cyrus Chargari; Isabelle Brocheriou-Spelle; Jean-Charles Soria
Journal:  Invest New Drugs       Date:  2011-04-21       Impact factor: 3.850

Review 2.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

3.  Minimal change disease onset observed after bevacizumab administration.

Authors:  Ramy M Hanna; Eduardo Lopez; James Wilson; Shrinath Barathan; Arthur H Cohen
Journal:  Clin Kidney J       Date:  2015-12-28

Review 4.  Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Authors:  Kenar D Jhaveri; Rimda Wanchoo; Vipulbhai Sakhiya; Daniel W Ross; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2016-09-21

5.  Development of Collapsing Focal and Segmental Glomerulosclerosis After Receiving Intravitreal Vascular Endothelial Growth Factor Blockade.

Authors:  Niloofar Nobakht; Hoang Anh Nguyen; Mohammad K Kamgar; Lama Abdelnour; Anjay Rastogi; Ramy M Hanna
Journal:  Kidney Int Rep       Date:  2019-08-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.